Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
YD Bio Limited, a Nasdaq-listed biopharmaceutical company, highlighted a new peer-reviewed study published in Bioengineering. Collaborating with Taipei Medical University researchers, YD Bio developed a data-driven computational framework, the Cargo Prioritization Score (CPS), to identify molecular candidates for potential stem-cell-based therapies…
Bitdeer AI, a NASDAQ-listed company, has secured a 16-year colocation lease agreement for 121 IT megawatts at its Tydal campus in Norway with Volta, backed by significant financial guarantees. The contract represents $4.7 billion in revenue with a potential extension to $8 billion, powering one of Norway's largest and most energy-efficient AI data …
PN Smart Energy Limited announced its financial results for the first half of fiscal 2026, reporting a 5.5% year-over-year increase in revenue to approximately $25.5 million, driven by international sales growth and new business ventures. Despite a net loss of $7.1 million primarily due to a non-cash share-based compensation charge, the company is …
Core Molding Technologies reported its Q2 fiscal 2026 results showing a slight decline in total production sales primarily due to weakness in the medium- and heavy-duty truck market, offset by strong growth in powersports, building products, industrial, and utilities markets. The company secured nearly $26 million in new business awards, mostly fro…
IZEA Worldwide, Inc., a leader in influencer marketing and creator economy solutions, announced its Q2 2026 earnings conference call to be held on August 11, 2026. The call will be hosted by the CEO and CFO and include a Q&A session.
Veea Inc. announced that MCN Build has implemented Veea's Crowdkeep platform at the Sidwell Friends School construction project in Washington, D.C., marking the tenth deployment of this platform by Genesys Impact for MCN Build. Crowdkeep leverages AI, edge computing, and IoT technologies to improve workforce accountability, safety, and operational …
Rein Therapeutics announced the peer-reviewed publication of its first-in-human LTI-03 clinical study data in Nature Communications, confirming safety and notable reductions in markers of lung scarring and inflammation in idiopathic pulmonary fibrosis (IPF) patients. These findings strengthen the scientific rationale for its ongoing Phase 2 RENEW t…
Enphase Energy reinforces its commitment to U.S.-based design and manufacturing of critical power electronics across residential and commercial solar, battery systems, electric vehicle chargers, and next-generation AI data center infrastructure. The company highlights its domestic production facilities in South Carolina and Texas and introduces the…
Aptera Motors Corp. has issued purchase orders for body and chassis components for its first 40 production vehicles, marking a major milestone in transitioning from validation builds to production. Deliveries of these components are expected to begin by October, supporting the company's plan to start production soon. The company is continuing to se…
CBL International Limited has regained compliance with Nasdaq's minimum bid price requirement after executing a 1-for-13 reverse stock split. Nasdaq confirmed the company's stock price has remained above $1.00 for 20 consecutive business days, allowing the company to maintain its listing on the Nasdaq Capital Market under ticker BANL.
CoreCivic announced a new five-year contract with U.S. Immigration and Customs Enforcement to reactivate its Prairie Correctional Facility, which has been idle since 2010. The 1,600-bed facility located in Minnesota will begin intake in Q4 2026, generating estimated annual revenue of approximately $75 million upon full ramp-up by mid-2027.
Mineralys Therapeutics, a biopharmaceutical company targeting hypertension and aldosterone-related diseases, will release its Q2 2026 financial results after market close on August 11, 2026, followed by a conference call and webcast for investors.
Exagen Inc. reported strong financial results for Q2 2026 with record revenue of $19.9 million, a 16% increase year-over-year, driven by growth in autoimmune test volume and higher average selling prices. The company reduced its net loss by nearly 30% compared to the prior year and significantly narrowed its adjusted EBITDA loss to $0.1 million. Ex…
<p>Nittobo (Nitto Boseki) sits under the radar but supplies advanced fibrous and thermal materials used in high-end consumer devices and high-performance compute. With end-market demand from major OEMs like Apple and semiconductor players such as Nvidia, the company is a candidate for a tactical long trade while product ramps and inventory normaliz…
Tapestry has turned leaner and more shareholder-friendly. Strong FCF, a meaningful buyback program in 2025, and consistent brand traction have compressed downside and set the stage for further multiple expansion. We upgrade our stance to a trade-buy for a mid-term rebound with clearly defined entry, target and stop levels.
YY Group Holding Limited completed the acquisition of a 95% interest in Xtreme Solutions Pte. Ltd., a profitable Singapore-incorporated distributor, for approximately SGD 4.5 million (USD 3.5 million). The acquisition is expected to be accretive to revenue and net profit starting the following quarter. YY Group plans to leverage its digital marketi…
Telesat Corporation has secured a $2.3 billion contract with Canada's Defence Investment Agency to deliver secure Mil-Ka satellite connectivity to the Canadian Armed Forces across the Arctic. This 15-year agreement expands Telesat Lightspeed constellation by 69 satellites to 225 total, increasing capacity by 44% and positioning Telesat for accelera…
Abeona Therapeutics announced that CMS has granted New Technology Add-On Payment (NTAP) status for its gene therapy ZEVASKYN, intended to treat wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB). NTAP status offers supplemental reimbursement above standard hospital payments, recognizing the therapy's clinical benefits and imp…
3D Systems disclosed that CEO Dr. Jeffrey Graves will retire later this year, with a successor to be appointed through an ongoing search process. Dr. Graves will continue as CEO until then and serve as a consultant afterward to ensure a smooth transition. The company highlights the strategic progress made under his leadership, including a focus on …
Creative Realities, Inc., a NASDAQ-listed provider of digital signage and media solutions, will report its financial results for Q2 2026 on August 13, 2026, before market open, followed by a conference call hosted by senior management. The company designs and deploys digital signage experiences and offers SaaS across various sectors including retai…
Harmony Biosciences announced a 30% year-over-year increase in Q2 2026 net revenue for WAKIX, reaching $261.3 million, driven by strong demand and commercial execution. Patient numbers grew by 450 to 8,950. The company reaffirmed its 2026 WAKIX net revenue guidance between $1.0 billion and $1.04 billion. Phase 1 data for BP-205, a potential best-in…
Zevra Therapeutics, a commercial-stage biotech company specializing in rare disease therapeutics, announced its executive leadership will present at the Canaccord Genuity 46th Annual Growth Conference to discuss corporate strategy and upcoming milestones. The company emphasizes its ongoing commercialization of therapies for Niemann-Pick disease typ…
Palvella Therapeutics reported second quarter 2026 financial results and a corporate update highlighting the submission of the first module of its rolling NDA for QTORIN™ rapamycin targeting microcystic lymphatic malformations, planned commercial launch in H1 2027, and upcoming clinical trial initiations for other QTORIN™ drug candidates. The compa…
Dyadic International announced a new strategic development and commercial license agreement with a European biotech firm to expand its portfolio of precision-fermented non-animal dairy proteins. This move enhances Dyadic's food and nutrition pipeline, building on existing collaborations and utilizing its proprietary Dapibus™ fermentation platform f…
Microchip Technology, in collaboration with Micron Technology, showcased an advanced PCIe Gen 6 storage architecture integrating Microchip's Switchtec Gen 6 PCIe switches with Micron's 9650 NVMe SSDs. This demonstration highlights enhanced data throughput, reduced latency, and scalable connectivity designed to meet the demanding requirements of AI,…
